PE20030613A1 - Compuestos de 1h-quinolin-2-ona sustituidos - Google Patents

Compuestos de 1h-quinolin-2-ona sustituidos

Info

Publication number
PE20030613A1
PE20030613A1 PE2002001054A PE2002001054A PE20030613A1 PE 20030613 A1 PE20030613 A1 PE 20030613A1 PE 2002001054 A PE2002001054 A PE 2002001054A PE 2002001054 A PE2002001054 A PE 2002001054A PE 20030613 A1 PE20030613 A1 PE 20030613A1
Authority
PE
Peru
Prior art keywords
quinolin
hydroxy
alkyl
compounds
substitute
Prior art date
Application number
PE2002001054A
Other languages
English (en)
Inventor
Helmut Buschmann
Werner Englberger
Babette-Yvonne Kogel
Michael Sattlegger
Michael Przewosny
Hans Schick
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20030613A1 publication Critical patent/PE20030613A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DE 1H-QUINOLIN-2-ONA SUSTITUIDOS DE FORMULA I DONDE R1, R2, R3 Y R4 SON ALQUILO C1-C10, CICLOALQUILO C3-C7 CON H, HALO, OH; R5 ES H, ALQUJILO C1-C10, ARILO, HETEROARILO, ENTRE OTROS; R6 ES OH, OR7 DONDE R7 ES ALQUILO C1-C10, CICLOALQUILO, C3-C6; A ES UN PUENTE DE FORMULA -(CH2)3-, -CH2-CH=CH-, -CH2COO-, -CH2CONH-, ENTRE OTROS; X ES UN HETEROCICLO. SON COMPUESTOS PREFERIDOS 2'-(7-CLORO-4-HIDROXI-2-OXO-1,2-DIHIDROQUINOLIN-3-IL)-N-[3''-(N,N-DIMETILAMINOMETIL)-4''-HIDROXI-4''-(m-METOXIFENIL)CICLOHEXIL]ACETAMIDA, 2'-(7-CLORO-4-METOXI-2-OXO-1,2-DIHIDROQUINOLIN-3-IL)-N-[3''-(N,N-DIMETILAMINOMETIL)-4''-HIDROXI-4''-(m-METOXIFENIL)CICLOHEXIL]ACETAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS MENCIONADOS SON UTILES PARA EL TRATAMIENTO DEL DOLOR
PE2002001054A 2001-10-29 2002-10-28 Compuestos de 1h-quinolin-2-ona sustituidos PE20030613A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10153347A DE10153347A1 (de) 2001-10-29 2001-10-29 Substituierte 1H-Chinolin-2-on-Verbindungen

Publications (1)

Publication Number Publication Date
PE20030613A1 true PE20030613A1 (es) 2003-07-26

Family

ID=7704097

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001054A PE20030613A1 (es) 2001-10-29 2002-10-28 Compuestos de 1h-quinolin-2-ona sustituidos

Country Status (11)

Country Link
US (1) US20040224980A1 (es)
EP (1) EP1442021A1 (es)
JP (1) JP2005511567A (es)
AR (1) AR037250A1 (es)
CA (1) CA2465306A1 (es)
DE (1) DE10153347A1 (es)
HU (1) HUP0401831A2 (es)
MX (1) MXPA04004090A (es)
PE (1) PE20030613A1 (es)
PL (1) PL369829A1 (es)
WO (1) WO2003037870A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
CN103382174A (zh) 2006-06-23 2013-11-06 雅培制药有限公司 作为组胺h3受体调节物的环丙胺衍生物
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
US20230027752A1 (en) * 2019-11-06 2023-01-26 Fudan University Opioid receptor agonist, preparation method therefor and pharmaceutical use thereof
CN112759546B (zh) * 2019-11-06 2022-08-26 复旦大学 3-(二甲氨基甲基)哌啶-4-醇衍生物及其制备方法和药物用途
CN112759545B (zh) * 2019-11-06 2022-12-13 复旦大学 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途
CN112759544B (zh) * 2019-11-06 2022-08-26 复旦大学 3-(二甲氨基甲基)哌啶-4-醇衍生物制备方法和药物用途
CN112759587B (zh) * 2019-11-06 2022-12-30 复旦大学 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
RS51019B (sr) * 1999-10-25 2010-10-31 Active Biotech Ab. Lekovi za lečenje malignih tumora
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate

Also Published As

Publication number Publication date
AR037250A1 (es) 2004-11-03
PL369829A1 (en) 2005-05-02
US20040224980A1 (en) 2004-11-11
DE10153347A1 (de) 2003-05-08
CA2465306A1 (en) 2003-05-08
JP2005511567A (ja) 2005-04-28
HUP0401831A2 (hu) 2004-12-28
EP1442021A1 (de) 2004-08-04
WO2003037870A1 (de) 2003-05-08
MXPA04004090A (es) 2004-07-08

Similar Documents

Publication Publication Date Title
GT200200191A (es) Derivados de 1,6-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
MY135841A (en) Novel benzodioxoles
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
PE20020858A1 (es) Indanil aminas aciladas
PE20030238A1 (es) Uso de los antagonistas del receptor nk-1 para el tratamiento de lesiones cerebrales, espinales y neuronales
ATE206611T1 (de) Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung
PE20030613A1 (es) Compuestos de 1h-quinolin-2-ona sustituidos
DE60202379D1 (de) Neuartige verbindungen
NO171059C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, disubstituerte benzylaminer
PE20030718A1 (es) Lactamas como antagonistas de taquiquininas
DK0647231T3 (da) N-substituerede 3-azabicyclo 3.2.0 heptanderivater til anvendelse som bl.a. neuroleptika
PE20040267A1 (es) Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
SE8505887L (sv) Indoler
ATE124045T1 (de) Substituierte imidazobenzazepine und imidazopyridoazepine.
PE20030510A1 (es) Indoles sustituidos
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
PE20021099A1 (es) Derivados de c-furano-2-il-metilamina sustituidos
DE69909811T2 (de) Substituierte isoxazolylthiophenverbindungen
WO2001038316A3 (de) Sulfonyloxazolamine und deren verwendung als 5-ht6 rezeptorliganden
ITMI920084A1 (it) Alchil derivati del trazodone
DE69808326D1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
BG96664A (bg) Антихипертензивно средство

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed